The neutrophil-to-lymphocyte ratio at the prostate-specific antigen nadir predicts the time to castration-resistant prostate cancer

被引：1
|
作者：
Iwamoto, Genta [1 ]
Kawahara, Takashi [1 ,2 ]
Yokomizo, Yumiko [2 ]
Miyoshi, Yasuhide [1 ]
Yao, Masahiro [2 ]
Uemura, Hiroji [2 ]
机构：
[1] Yokohama City Univ, Med Ctr, Dept Urol & Renal Transportat, Yokohama, Kanagawa, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa, Japan
来源：
ASIAN JOURNAL OF UROLOGY | 2021年 / 8卷 / 03期
关键词：
D O I：
10.1016/j.ajur.2020.05.006
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：332 / 334
页数：3
相关论文
共 50 条
  • [41] Nadir prostate-specific antigen best predicts the progression to androgen-independent prostate cancer
    Morote, J
    Trilla, E
    Esquena, S
    Abascal, JM
    Reventos, J
    INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (06) : 877 - 881
  • [42] A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time
    Noguchi, Masanori
    Moriya, Fukuko
    Suekane, Shigetaka
    Ohnishi, Rei
    Matsueda, Satoko
    Sasada, Tetsuro
    Yamada, Akira
    Itoh, Kyogo
    BMC CANCER, 2013, 13
  • [43] A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time
    Masanori Noguchi
    Fukuko Moriya
    Shigetaka Suekane
    Rei Ohnishi
    Satoko Matsueda
    Tetsuro Sasada
    Akira Yamada
    Kyogo Itoh
    BMC Cancer, 13
  • [44] Prostate-specific Antigen Progression in Enzalutamide-treated Men with Nonmetastatic Castration-resistant Prostate Cancer: Any Rise in Prostate-specific Antigen May Require Closer Monitoring
    Saad, Fred
    Sternberg, Cora N.
    Efstathiou, Eleni
    Fizazi, Karim
    Modelska, Katharina
    Lin, Xun
    Sugg, Jennifer
    Steinberg, Joyce
    Noerby, Bettina
    Shore, Neal D.
    Hussain, Maha
    EUROPEAN UROLOGY, 2020, 78 (06) : 847 - 853
  • [45] The Pretherapeutic Neutrophil-to-Lymphocyte Ratio for Docetaxel-Based Chemotherapy Is Useful for Predicting the Prognosis of Japanese Patients with Castration-Resistant Prostate Cancer
    Tatenuma, Tomoyuki
    Kawahara, Takashi
    Hayashi, Narihiko
    Hasumi, Hisashi
    Makiyama, Kazuhide
    Nakaigawa, Noboru
    Kishida, Takeshi
    Miyoshi, Yasuhide
    Yao, Masahiro
    Uemura, Hiroji
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [46] The change in expression of prostate-specific membrane antigen in circulating tumor cells during treatments for castration-resistant prostate cancer
    Nagaya, N.
    Kanayama, M.
    Nagata, M.
    Horie, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [47] Prostate-specific antigen flare induced by 223RaCl2 in patients with metastatic castration-resistant prostate cancer
    Angelo Castello
    H. A. Macapinlac
    E. Lopci
    E. B. Santos
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 2256 - 2263
  • [48] Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer
    Nagaya, Naoya
    Nagata, Masayoshi
    Lu, Yan
    Kanayama, Mayuko
    Hou, Qi
    Hotta, Zen-u
    China, Toshiyuki
    Kitamura, Kosuke
    Matsushita, Kazuhito
    Isotani, Shuji
    Muto, Satoru
    Sakamoto, Yoshiro
    Horie, Shigeo
    PLOS ONE, 2020, 15 (01):
  • [49] Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer
    Xu, Xu Steven
    Ryan, Charles J.
    Stuyckens, Kim
    Smith, Matthew R.
    Saad, Fred
    Griffin, Thomas W.
    Park, Youn C.
    Yu, Margaret K.
    De Porre, Peter
    Vermeulen, An
    Poggesi, Italo
    Nandy, Partha
    CLINICAL PHARMACOKINETICS, 2017, 56 (01) : 55 - 63
  • [50] Current role of prostate-specific membrane antigen-based imaging and radioligand therapy in castration-resistant prostate cancer
    Chen, Jiaxian
    Qi, Lin
    Tang, Yongxiang
    Tang, Guyu
    Gan, Yu
    Cai, Yi
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
12345